Table 2 Primary and secondary endpoints (full analysis set)
|  | Budesonide (N = 103) | Placebo (N = 103) | P |
|---|---|---|---|
L.S. Mean (S.E.)a | L.S. Mean (S.E.)a | ||
rTNSS | − 2.20 (0.147) | − 1.72 (0.148) | 0.0107 |
SGIC | − 2.35 (0.085) | − 2.20 (0.085) | 0.1047 |
NO | − 0.73 (0.058) | − 0.60 (0.059) | 0.0671 |
Secretion/RN | − 0.72 (0.054) | − 0.61 (0.055) | 0.0781 |
Itching/SN | − 0.75 (0.055) | − 0.51 (0.056) | 0.0009 |
NO + RN | − 1.45 (0.102) | − 1.21 (0.104) | 0.0520 |
NO + SN | − 1.48 (0.102) | − 1.11 (0.103) | 0.0057 |
RN + SN | − 1.47 (0.100) | − 1.12 (0.101) | 0.0065 |
Cough | − 0.28 (0.052) | − 0.22 (0.053) | 0.183 |
Postnasal drip | − 0.55 (0.051) | − 0.45 (0.052) | 0.079 |